Genomic stability prevails in North-African hepatocellular carcinomas

Dig Liver Dis. 2007 Jul;39(7):671-7. doi: 10.1016/j.dld.2007.03.012. Epub 2007 May 25.

Abstract

The molecular pathogenesis of hepatocellular carcinoma, a tumour characterized by a vast clinical heterogeneity, remains unexplored outside Europe and Eastern Asia. We analysed by direct sequencing or loss of heterozygosity assay, the common targets of genomic alterations in 42 hepatocellular carcinomas collected in western North-Africa. Overall, genomic instability was uncommon, allelic losses affecting mostly chromosomes 1p, 4q, 8p and 17p (24-28% of cases). CTNNB1 and TP53 were infrequently mutated (9 and 17% of cases, respectively). Surprisingly, TP53 mutation R249S, diagnostic of aflatoxin B1 exposure, usually frequent in Africa, was exceptional (one case), indicating that in western North-Africa, hepatocellular carcinoma genetics differs markedly from that of the remainder of the continent.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Hepatocellular / epidemiology
  • Carcinoma, Hepatocellular / genetics*
  • Female
  • Genes, p53 / genetics
  • Genetic Heterogeneity
  • Genomic Instability*
  • Humans
  • Liver Neoplasms / epidemiology
  • Liver Neoplasms / genetics*
  • Loss of Heterozygosity
  • Male
  • Middle Aged
  • Morocco / ethnology
  • Mutation
  • Tunisia / ethnology
  • beta Catenin / genetics

Substances

  • CTNNB1 protein, human
  • beta Catenin